However, their value in the management of uncomplicated skin infections is not yet clearly defined. This literature review discusses various topical antibiotic treatment options for uncomplicated ...
(IN BRIEF) Researchers at Empa and the Cantonal Hospital of St. Gallen are developing new nanocomplexes to combat antibiotic-resistant bacteria and protect eye tissue following cataract surgery.
When bacteria become resistant to antibiotics, it makes it more difficult to treat diseases caused by those bacteria and limits the treatment options. Alternative treatments may be costly and, in some ...
IRX-101 is under clinical development by IRenix Medical and currently in Phase III for Eye Infections. According to GlobalData, Phase III drugs for Eye Infections have a 43% phase transition success ...
Introduction: The preoperative phase is an important period in which to prevent surgical site infections (SSIs). Prophylactic antibiotic use helps to reduce SSI rates, leading to reductions in ...